|
⚲
|
| Keyboard |
| Braeden Lichti | |
|---|---|
| Firm | |
| Address | 233 Ayer Road, Suite 4 Harvard, MA 01451 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Aquabounty Technologies Inc | 021-589242 | Director | 2.2 M of 2.2 M |
||
| Aquabounty Technologies Inc | 021-562934 | Director | 4.0 M of 4.0 M |
||
| Qualigen Therapeutics Inc | 021-554645 | Director | 4.5 M of 4.5 M |
||
| Qualigen Therapeutics Inc | 021-530306 | Director | 5.1 M of 5.1 M |
||
| Elevai Labs Inc | 021-492846 | Promoter | 0.2 M of 0.5 M |
||
| Elevai Labs Inc | 021-480130 | Promoter | 0.5 M of 1.6 M |
||
| Elevai Labs Inc | 021-454010 | Executive Officer | 3.0 M of 4.3 M |
||
| Elevai Labs Inc | 021-415465 | Executive Officer | 1.1 M of 2.0 M |
||
| Reactive Medical Labs Inc | 021-415461 | Executive Officer | 0.1 M of 0.1 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PMGC Holdings Inc ELAB
Series B Preferred Stock
|
2025-03-26 | Grant | 3,336,437 | $0.00 | |
|
Marizyme Inc MRZM
Common stock
|
2023-12-21 | Conversion | 3,815,294 | $0.10 | 381,529 |
|
Marizyme Inc MRZM
10% Secured Convertible Promissory Note · derivative
|
2023-12-21 | Conversion | 2 | $0.00 | |
|
Marizyme Inc MRZM
Common shares
|
2023-08-29 | Buy | 105,000 | $0.17 | 17,850 |
|
Marizyme Inc MRZM
Common shares
|
2023-07-07 | Buy | 97,000 | $0.10 | 9,700 |
|
Marizyme Inc MRZM
Common shares
|
2023-06-29 | Buy | 106,327 | $0.09 | 9,569 |